Search - tctmd.com

Displaying 661 - 680 of 1277

Sort: Relevancy | Date

Presentation

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Presenter: E. Perdoncin

December 10, 2013

News Daily News

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

December 10, 2013

News Daily News

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

December 05, 2013

News Daily News

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

December 05, 2013

Presentation

Establishing Evidence in the Field of Renal Denervation: The EnligHTN Clinical Evidence Series

Presenter: Mel Lobo

December 01, 2013

Presentation

Attack on the Sympathetic System: Locations for Denervation Besides the Renal Artery

Presenter: William A. Gray

December 01, 2013

Presentation

Why is there So Much Excitement Over Renal Denervation?

Presenter: Michael R. Jaff

December 01, 2013

Presentation

What We Don’t Know, But Need to Know About Renal Denervation

Presenter: Krishna Rocha-Singh

December 01, 2013

Presentation

Renal Denervation - Cardiosonic Update: The Hypertension Specialist’s Perspective

Presenter: Mel Lobo

December 01, 2013

Presentation

OneShot™ Renal Denervation System: Clinical Program Update

Presenter: Eberhard Grube

December 01, 2013

Presentation

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

Presenter: Eli Lev

December 01, 2013

News Conference News AHA 2013

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

November 24, 2013

News Daily News

Los Vasos modificados mediante Bioingeniería parecen Seguros para su Uso en Pacientes a Diálisis

November 21, 2013

News Daily News

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

November 21, 2013

News Conference News AHA 2013

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

Yael L. Maxwell

November 20, 2013

News Conference News AHA 2013

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Yael L. Maxwell

November 19, 2013

News Conference News AHA 2013

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Jason Kahn

November 17, 2013

News Conference News AHA 2013

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Jason Kahn

November 16, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

Presentation TCT 2013

Renal Denervation with the ReCor Paradise Device: One Simple and One Not-So-Simple Case

Presenter: Joost Daemen

October 31, 2013

Advertisement

Impact of Worsening Renal Dysfunction on the Comparative Efficacy of Bivalirudin and Platelet GPIs

Bivalirudin Lowers Post-PCI Bleeding Risk Across All Renal Dysfunction Categories

Más Gasto en Pacientes EAP No arroja Beneficio alguno en los Índices de Amputación

Higher Spending in PAD Patients Yields No Benefit in Amputation Rates

Establishing Evidence in the Field of Renal Denervation: The EnligHTN Clinical Evidence Series

Attack on the Sympathetic System: Locations for Denervation Besides the Renal Artery

Why is there So Much Excitement Over Renal Denervation?

What We Don’t Know, But Need to Know About Renal Denervation

Renal Denervation - Cardiosonic Update: The Hypertension Specialist’s Perspective

OneShot™ Renal Denervation System: Clinical Program Update

Beyond Hypertension - “Off-target” Effects of Renal Denervation in Hypertensive Patients

AHA 2013: Mix of Positive, Negative Trials Help Guide Interventional Practice

Los Vasos modificados mediante Bioingeniería parecen Seguros para su Uso en Pacientes a Diálisis

Bioengineered Vessels Appear Safe for Use in Dialysis Patients

Risk of Kidney Injury Not Affected by High-Potency Statin Regimen in ACS Patients

RADAR-AF: HF Source Ablation Does Not Benefit Paroxysmal, Persistent A-fib Patients

Renal Stenting Fails to Improve Outcomes vs. Medical Therapy Alone in RAS Patients

Registry Study Summarizes Initial US Experience with First Approved TAVR Device

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Renal Denervation with the ReCor Paradise Device: One Simple and One Not-So-Simple Case

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content